Concepedia

Thomas Taillier

TT

2

Publications

57

Citations

2

H-Index

2018

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

Sanofi (France)

Thomas Taillier is an author at GlaxoSmithKline (United States) specializing in drug discovery, antimicrobial resistance, and drug resistance.

Top concepts

MedicineAntibioticsMicrobiologyPharmacologyDrug DiscoveryDrug ResistancePharmacotherapyNatural SciencesCombination TherapyMedicinal Chemistry

Publications per year

2018–2018

2

Publications

2

A new class of antibacterials, the imidazopyrazinones, reveal structural transitions involved in DNA gyrase poisoning and mechanisms of resistance

Thomas Germe, Judit Vörös, Frédéric Jeannot et al. · Nucleic Acids Research · 2018 · 43 citations · Full text

Imidazopyrazinones (IPYs): Non-Quinolone Bacterial Topoisomerase Inhibitors Showing Partial Cross-Resistance with Quinolones

Frédéric Jeannot, Thomas Taillier, Pierre Despeyroux et al. · Journal of Medicinal Chemistry · 2018 · 14 citations · Full text

Bioorganic Chemistry, Pharmacotherapy, Antimicrobial Chemotherapy +16

Rows per page

1–2 of 2